6.21
肾衰竭：剂量调整
对于肾功能不全的患者，药物的药代动力学会发生显著变化，需要调整剂量以确保治疗安全有效。
肾功能不全通常会导致肾清除率和消除率降低。这些变化导致药物的消除半衰期延长和表观分布容积改变。因此，通常需要调整剂量以维持体内最佳药物水平。
但是，并非所有情况都需要剂量调整。当未改变的药物排泄分数 (f_u)…
肾功能损害患者的药物表现出改变的药代动力学特征。
肾清除率和消除速率降低导致消除半衰期延长，因此需要调整剂量。
当药物的非结合分数 fu、原形药物排泄分数 ≤ 0.3，且肾功能 RF 为正常值的 ≥ 0.7 时，无需调整给药方案。
这一假设依赖于代谢物无活性、结合特性不变，以及在肾功能衰竭期间药物持续可利用。
然而，随着 fu 当接近1且RF趋近于零时，消除过程显著减慢，需要大幅减少剂量。
在这些情况下，非肾脏清除率变得更为重要。
一个简单的方程可计算肾功能损害患者所需的剂量。
同样，给药间隔也可以计算得出。
对于治疗指数较低的药物，通常需要进行剂量调整。
View the full transcript and gain access to JoVE Core videos
Q1: When do patients with renal impairment not need dose adjustments?
Dosage adjustments are unnecessary when the fraction of drug excreted unchanged (fu) is ≤ 0.3 and renal function (RF) is ≥ 0.7 of normal. This assumes metabolites remain inactive, protein-binding characteristics stay unchanged, and drug availability is sustained during renal failure. Under these conditions, renal clearance reduction does not significantly impact drug elimination.
Q2: How does renal impairment change drug elimination half-life?
Renal impairment reduces renal clearance and elimination rate, prolonging the drug's elimination half-life. This extended half-life means the drug remains in the body longer, increasing the risk of accumulation. Prolonged half-life is a key reason why dose adjustments become necessary in patients with compromised renal function.
Q3: What role does nonrenal clearance play when kidney function declines?
As renal clearance decreases, nonrenal clearance—including hepatic metabolism and other elimination pathways—gains prominence in removing drugs from the body. Understanding the interplay between renal and nonrenal clearance is crucial for determining appropriate dosage adjustments. When fu approaches unity and renal function nears zero, nonrenal routes become the primary elimination mechanism.
Q4: Why do drugs with high fraction excreted unchanged require substantial dose reduction?
Drugs with fu approaching unity are eliminated primarily through the kidneys. As renal function declines toward zero, elimination slows significantly, causing drug accumulation and potential toxicity. Substantial dose reduction is necessary to prevent toxic levels while maintaining therapeutic effectiveness in patients with severe renal impairment.
Q5: Which drugs require the most careful dose adjustment in renal failure?
Drugs with low therapeutic indices require the most careful dose adjustments in renal failure. These drugs have a narrow margin between therapeutic and toxic doses, making it critical to maintain drug levels within the therapeutic range. Even small accumulations from reduced renal clearance can cause toxicity in patients with renal impairment.
Q6: How can clinicians calculate appropriate doses for renally impaired patients?
A simple equation calculates the required dose in patients with renal impairment by accounting for changes in drug clearance. Similarly, the dosing interval can be computed based on the drug's half-life and desired drug concentrations. These calculations ensure optimal drug levels while preventing accumulation and toxicity.
Q7: What assumptions must hold for drugs with low renal excretion to avoid dose adjustment?
For drugs with fu ≤ 0.3 to avoid dose adjustment despite renal impairment, three assumptions must hold: drug metabolites must be inactive, protein-binding characteristics must remain unchanged, and drug availability must be sustained during renal failure. If any assumption fails, dose adjustments become necessary even for drugs with low renal excretion.